Jacques Col

8.4k total citations · 2 hit papers
42 papers, 3.6k citations indexed

About

Jacques Col is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jacques Col has authored 42 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jacques Col's work include Acute Myocardial Infarction Research (25 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac Imaging and Diagnostics (8 papers). Jacques Col is often cited by papers focused on Acute Myocardial Infarction Research (25 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac Imaging and Diagnostics (8 papers). Jacques Col collaborates with scholars based in Belgium, United States and Canada. Jacques Col's co-authors include Philip E. Aylward, Eric J. Topol, Amadeo Betriu, Lynn H. Woodlief, Kerry L. Lee, Robert M. Califf, Judith S. Hochman, W. Douglas Weaver, Frans Van de Werf and Lynn A. Sleeper and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jacques Col

40 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction

1995 877 citations Eric J. Topol, W. Douglas Weaver et al. Circulation profile →
Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

2009 582 citations Shamir R. Mehta, Christopher B. Granger et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Col Belgium	23	2.9k	1.6k	975	850	718	42	3.6k
David Hasdai Israel	28	2.1k 0.7×	1.1k 0.7×	708 0.7×	502 0.6×	384 0.5×	89	2.7k
Earl E. Smith United States	12	2.2k 0.8×	785 0.5×	757 0.8×	212 0.2×	337 0.5×	17	2.8k
Amanda Stebbins United States	33	2.8k 1.0×	961 0.6×	653 0.7×	473 0.6×	415 0.6×	81	3.3k
Menko‐Jan de Boer Netherlands	36	5.0k 1.8×	2.9k 1.8×	2.5k 2.6×	279 0.3×	603 0.8×	138	6.0k
Frank Vermeer Netherlands	19	2.1k 0.7×	941 0.6×	1.0k 1.0×	149 0.2×	216 0.3×	50	2.5k
Mark B. Effron United States	30	2.4k 0.8×	1.5k 0.9×	375 0.4×	223 0.3×	411 0.6×	118	3.4k
André Lamy Canada	32	3.0k 1.0×	1.6k 1.0×	670 0.7×	270 0.3×	283 0.4×	130	4.2k
Jindřich Špinar Czechia	24	2.2k 0.8×	928 0.6×	164 0.2×	603 0.7×	518 0.7×	117	3.1k
Jan‐Henk E. Dambrink Netherlands	30	3.3k 1.2×	2.0k 1.2×	1.2k 1.2×	118 0.1×	298 0.4×	87	4.0k
Lynn H. Woodlief United States	15	2.0k 0.7×	801 0.5×	831 0.9×	113 0.1×	235 0.3×	26	2.4k

Countries citing papers authored by Jacques Col

Since Specialization

Citations

This map shows the geographic impact of Jacques Col's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Col with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Col more than expected).

Fields of papers citing papers by Jacques Col

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Col. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Col. The network helps show where Jacques Col may publish in the future.

Co-authorship network of co-authors of Jacques Col

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Col. A scholar is included among the top collaborators of Jacques Col based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Col. Jacques Col is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ambroise, Jérôme, et al.. (2015). Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock’s clinical score in predicting heart failure outcomes. Quality of Life Research. 25(5). 1245–1255. 3 indexed citations

Mehta, Shamir R., Christopher B. Granger, William E. Boden, et al.. (2009). Early versus Delayed Invasive Intervention in Acute Coronary Syndromes. New England Journal of Medicine. 360(21). 2165–2175. 582 indexed citations breakdown →

French, J., Shannon Harkness, Lynn A. Sleeper, et al.. (2009). Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry). The American Journal of Cardiology. 104(1). 24–28.

Mahaffey, Kenneth W., Qinghong Yang, Karen S. Pieper, et al.. (2008). Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial. Journal of General Internal Medicine. 23(3). 310–316. 38 indexed citations

Mahaffey, Kenneth W., Simon T. Tonev, Sarah A. Spinler, et al.. (2008). Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial. International Journal of Cardiology. 139(2). 123–133. 39 indexed citations

Stone, Gregg W., Robert M. Clare, Kenneth W. Mahaffey, et al.. (2006). Impact of enoxaparin on thrombus formation, coronary blood flow, and myocardial perfusion after early invasive treatment during acute coronary syndrome: Results from the SYNERGY library. Circulation. 114(18). 600–600. 6 indexed citations

Boden, William E., Wiek H. van Gilst, Ian R. Starkey, et al.. (2000). Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. The Lancet. 355(9217). 1751–1756. 54 indexed citations

Slater, James, Robert Brown, Venu Menon, et al.. (2000). Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 36(3). 1117–1122. 112 indexed citations

Jacobs, Alice K., J. French, Jacques Col, et al.. (2000). Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 36(3). 1091–1096. 53 indexed citations

10.

Jacquet, Luc, et al.. (1998). Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 13(4). 378–384. 48 indexed citations

11.

Anderson, R. David, E. Magnus Ohman, David R. Holmes, et al.. (1997). Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.. Journal of the American College of Cardiology. 30(3). 708–715. 114 indexed citations

12.

Newby, L. Kristin, Robert M. Califf, Alan D. Guerci, et al.. (1996). Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial. Journal of the American College of Cardiology. 27(3). 625–632. 84 indexed citations

13.

Mahaffey, Kenneth W., Christopher B. Granger, Rory Collins, et al.. (1996). Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. The American Journal of Cardiology. 77(8). 551–556. 47 indexed citations

14.

Col, Jacques, et al.. (1992). Infusion of Heparin Conjunct To Streptokinase Accelerates Reperfusion of Acute Myocardial-infarction - Results of a Double-blind Randomized Study (osiris). Digital Access to Libraries. 86(4). 259–259. 20 indexed citations

15.

Renkin, Jean, et al.. (1991). Cardiac tamponade early after thrombolysis for acute myocardial infarction: A rare but not reported hemorrhagic complication. Journal of the American College of Cardiology. 17(1). 280–285. 27 indexed citations

16.

Col, Jacques, et al.. (1989). Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction. The American Journal of Cardiology. 63(17). 1185–1192. 6 indexed citations

17.

Renkin, Jean, et al.. (1987). Absolute Diameter of the Dilated Segment - the Most Powerful Predictor of Restenosis After Coronary Angioplasty. Digital Access to Libraries. 76(4). 372–372. 2 indexed citations

18.

Goenen, Martin, et al.. (1985). Amrinone in the management of low cardiac output after open heart surgery. The American Journal of Cardiology. 56(3). B33–B38. 77 indexed citations

19.

Col, Jacques, et al.. (1984). Early changes in sodium and water balances in patients with acute myocardial infarction: relationship to haemodynamics and creatine kinase. European Journal of Clinical Investigation. 14(4). 247–254. 6 indexed citations

20.

Col, Jacques, et al.. (1982). Hemodynamic-effects of Ar-l115 Bs in Severe Chronic Congestive Heart-failure. European Journal of Clinical Investigation. 12(2). 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact